Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, September 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Quansys Biosciences Releases Q-Plex™ Pneumococcal Array (14-plex)
Wednesday, July 02, 2014
Company will launch the product at annual meeting of the AACC on July 28th 2014.

Thermo Scientific Launches New CellInsight CX5 HCS Platform
Wednesday, July 02, 2014
New high content screening platform for quantitative cell-based imaging.

Olink Bioscience Introduces a 92-protein Biomarker Panel
Wednesday, July 02, 2014
Proseek® Multiplex Inflammation I 96x96 for inflammatory diseases.

DynaPro® Plate Reader Optimizes Screening Process for Biotherapeutic Candidates
Wednesday, July 02, 2014
The high-throughput DynaPro Plate Reader utilizes dynamic light scattering to identify most promising mAb buffer conditions prior to extended stability testing.

New PAMAS AS3 Autosampling System from PAMAS
Tuesday, July 01, 2014
New particle counting system to analyze high quantities of samples.

Serial Dilution in 96- & 384-well Microplates
Monday, June 30, 2014
INTEGRA has introduced a Row Dilution Plate Holder accessory for its VIAFLO 96 and 384 handheld benchtop pipettes.

GE Healthcare Launches Cytell™ Cell Imaging System
Wednesday, June 25, 2014
Streamlines data acquisition, analysis and visualization.

Consistent & Efficient Purification of NGS Library Reactions
Tuesday, June 24, 2014
MagSi-NGSPREP offers an efficient solution for DNA clean-up and size selection.

Molecular Devices to attend 9th FENS Forum of Neuroscience 2014
Tuesday, June 24, 2014
Company will be showcasing its range of Axon Instruments at FENS 2014 (Hall 4, Booth 146) in Milan from 5 July 2014.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 2573
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv